SCHEMBL7554084

SCHEMBL7554084

CNC(=O)c1ccc(-c2ccc(-c3noc(C)n3)cc2)cc1

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.97
HDAC4 P56524 6/20 0.63
HDAC6 Q9UBN7 4/20 0.63
SMYD3 Q9H7B4 1/20 0.59
LMNA P02545 3/20 0.52
RAB9A P51151 2/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
HTT P42858 2/20 0.52
HPGD P15428 1/20 0.52
MAPK14 Q16539 2/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
IGF1R P08069 1/20 0.49
MET P08581 1/20 0.49
SRC P12931 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11962152 0.98 PLK1 (1.00) PLK1HDAC4HDAC6SMYD3LMNA
SCHEMBL6807698 0.82 PLK1 (0.67) PLK1SMYD3LMNARAB9ATSHR
SCHEMBL27574154 0.82 PLK1 (0.71) PLK1HDAC4HDAC6SMYD3LMNA
SCHEMBL8792955 0.81 PLK1 (0.65) PLK1HDAC4HDAC6SMYD3LMNA
SCHEMBL25813767 0.81 PLK1 (0.69) PLK1HDAC6MAPK14L3MBTL1TP53
SCHEMBL25463237 0.80 PLK1 (0.69) PLK1SMYD3LMNARAB9ATSHR
SCHEMBL326978 0.80 PLK1 (0.69) PLK1SMYD3LMNARAB9ATSHR
SCHEMBL18212490 0.80 PLK1 (0.68) PLK1HDAC4HDAC6SMYD3MAPK14
SCHEMBL13938063 0.79 PLK1 (0.68) PLK1SMYD3LMNARAB9ATSHR
SCHEMBL13415301 0.79 L3MBTL1 (0.69) PLK1SMYD3LMNARAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed
EP-0819126-A1 BIPHENYLAMIDE DERIVATIVES AS 5HT 1D? ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-01-21 EP disclosed
EP-0787133-A1 TRICYCLIC SPIRO COMPOUNDS PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-08-06 EP disclosed
WO-1996031508-A1 BIPHENYLAMIDE DERIVATIVES AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-10-10 WO disclosed
EP-0733048-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-09-25 EP disclosed
WO-1995015954-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-15 WO disclosed